Figure 1 | Hypertension Research

Figure 1

From: Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats

Figure 1

Systolic blood pressure in Wistar-Kyoto (WKY) rats (open circles) and placebo (closed circles)-, candesartan (closed triangles)-, candesartan plus amlodipine (closed squares)- and candesartan plus hydrochlorothiazide (HCTZ) (closed diamonds)-treated stroke-prone spontaneously hypertensive rats (SHR-SP) at 0, 1 and 2 weeks after starting treatment. **P< 0.01 vs. placebo-treated SHR-SP. ##P< 0.01 vs. candesartan-treated SHR-SP.

Back to article page